Solanki, B. B., Juergens, C., Chopada, M. B., Supe, P., Sundaraiyer, V., Le Dren-Narayanin, N., . . . Schmoele-Thoma, B. (2017). Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in adults 50 to 65 years of age in India: An open-label trial. Hum Vaccin Immunother.
Chicago Style CitationSolanki, Bhagirath B., et al. "Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Adults 50 to 65 years of Age in India: An Open-label Trial." Hum Vaccin Immunother 2017.
Cita MLASolanki, Bhagirath B., et al. "Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Adults 50 to 65 years of Age in India: An Open-label Trial." Hum Vaccin Immunother 2017.
Atenció: Aquestes cites poden no estar 100% correctes.